González-Gómez et al., 2019 - Google Patents
Development of superparamagnetic nanoparticles coated with polyacrylic acid and aluminum hydroxide as an efficient contrast agent for multimodal imagingGonzález-Gómez et al., 2019
View HTML- Document ID
- 2088189132942888848
- Author
- González-Gómez M
- Belderbos S
- Yañez-Vilar S
- Piñeiro Y
- Cleeren F
- Bormans G
- Deroose C
- Gsell W
- Himmelreich U
- Rivas J
- Publication year
- Publication venue
- Nanomaterials
External Links
Snippet
Early diagnosis of disease and follow-up of therapy is of vital importance for appropriate patient management since it allows rapid treatment, thereby reducing mortality and improving health and quality of life with lower expenditure for health care systems. New …
- 239000002105 nanoparticle 0 title abstract description 188
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| González-Gómez et al. | Development of superparamagnetic nanoparticles coated with polyacrylic acid and aluminum hydroxide as an efficient contrast agent for multimodal imaging | |
| Cędrowska et al. | Trastuzumab conjugated superparamagnetic iron oxide nanoparticles labeled with 225AC as a perspective tool for combined α-radioimmunotherapy and magnetic hyperthermia of HER2-positive breast cancer | |
| Stueber et al. | Magnetic nanoparticles in biology and medicine: past, present, and future trends | |
| Forte et al. | Radiolabeled PET/MRI nanoparticles for tumor imaging | |
| Farinha et al. | A comprehensive updated review on magnetic nanoparticles in diagnostics | |
| Kostevšek | A review on the optimal design of magnetic nanoparticle-based T 2 MRI contrast agents | |
| Jarockyte et al. | Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals | |
| Mrówczyński et al. | Cyclodextrin-based magnetic nanoparticles for cancer therapy | |
| Zhu et al. | Nanoparticle-based systems for T 1-weighted magnetic resonance imaging contrast agents | |
| Du et al. | Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI) | |
| Martínez-González et al. | Liposomes loaded with hydrophobic iron oxide nanoparticles: suitable T2 contrast agents for MRI | |
| Gawęda et al. | Trastuzumab modified barium ferrite magnetic nanoparticles labeled with radium-223: A new potential radiobioconjugate for alpha radioimmunotherapy | |
| Nieciecka et al. | Hybrid system for local drug delivery and magnetic hyperthermia based on SPIONs loaded with doxorubicin and epirubicin | |
| Karageorgou et al. | Gallium‐68 Labeled Iron Oxide Nanoparticles Coated with 2, 3‐Dicarboxypropane‐1, 1‐diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof‐of‐Concept Study | |
| Żuk et al. | Hybrid radiobioconjugated superparamagnetic iron oxide-based nanoparticles for multimodal cancer therapy | |
| Kostopoulou et al. | Iron oxide colloidal nanoclusters as theranostic vehicles and their interactions at the cellular level | |
| Kozlova et al. | Magnetic Composite Submicron Carriers with Structure-Dependent MRI Contrast | |
| Ahmad et al. | Functionalized lanthanide oxide nanoparticles for tumor targeting, medical imaging, and therapy | |
| Strbak et al. | Influence of dextran molecular weight on the physical properties of magnetic nanoparticles for hyperthermia and MRI applications | |
| Żuk et al. | Multifunctional nanoparticles based on iron oxide and gold-198 designed for magnetic hyperthermia and radionuclide therapy as a potential tool for combined HER2-positive cancer treatment | |
| Chauhan et al. | Targeted gold nanoparticle–oligonucleotide contrast agents in combination with a new local voxel-wise MRI analysis algorithm for in vitro imaging of triple-negative breast cancer | |
| Marasini et al. | Synthesis, Characterizations, and 9.4 tesla T2 MR images of polyacrylic acid-coated terbium (III) and holmium (III) oxide nanoparticles | |
| Kratz et al. | MPI phantom study with a high-performing multicore tracer made by coprecipitation | |
| Szigeti et al. | Thallium Labeled Citrate‐Coated Prussian Blue Nanoparticles as Potential Imaging Agent | |
| Kratz et al. | Tailored magnetic multicore nanoparticles for use as blood pool MPI tracers |